Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors
Ming Zhang(The University of Texas MD Anderson Cancer Center), Faye M. Johnson(The University of Texas MD Anderson Cancer Center), Lerong Li(The University of Texas MD Anderson Cancer Center), Tuhina Mazumdar(The University of Texas MD Anderson Cancer Center), Jeffrey N. Myers(The University of Texas MD Anderson Cancer Center), Curtis R. Pickering(The University of Texas MD Anderson Cancer Center), Vaishnavi Sambandam(National Comprehensive Cancer Network), Nene N. Kalu(The University of Texas MD Anderson Cancer Center), Mitchell J. Frederick(The University of Texas MD Anderson Cancer Center), Jing Wang(The University of Texas MD Anderson Cancer Center), Li Shen(The University of Texas MD Anderson Cancer Center), Pan Tong(The University of Texas MD Anderson Cancer Center), Shaohua Peng(The University of Texas MD Anderson Cancer Center), Ratnakar Singh(University of Illinois Urbana-Champaign)
Cited by 30
Related Papers
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
|Science Translational Medicine|2015|502
Extracapsular spread
|Cancer|2001|330
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
|Cancer Discovery|2023|181